secwatch.observer — SEC 8-K summary
======================================

Issuer:     CareDx, Inc. (CDNA)
CIK:        0001217234
Form:       8-K
Filed at:   2023-11-08T23:59:59+00:00
Accession:  0001217234-23-000224
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CareDx Q3 revenue $67.2M (-15% YoY); net loss $23.5M; raises FY2023 guidance to $274-278M
--------------------------------------------------------------------------------

- Revenue $67.2M (-15% YoY); testing services $47.8M (-26% YoY).
- Net loss $23.5M ($0.43 loss per share) vs $16.9M loss ($0.32 loss per share) in Q3 2022; non-GAAP loss $9.6M.
- Adjusted EBITDA loss $10.9M, compared to loss $2.5M in Q3 2022.
- Raised full-year 2023 revenue guidance to $274-278M from prior outlook.
- SEC concluded inquiry with no enforcement action; Medicare coverage for HeartCare and AlloSure Lung.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1217234/000121723423000224/0001217234-23-000224-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1217234/000121723423000224/cdna-20231108.htm
  HTML page:      https://secwatch.observer/filing/0001217234-23-000224

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer